Difference between revisions of "Main Page Mobile"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "?Variant |limit=10000|format=sum}} variants" to "?Variant |limit=10000|format=sum}} variants")
m (Text replacement - "http://hemonc.org" to "https://hemonc.org")
 
(15 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
='''HemOnc.org - A Free Hematology/Oncology Reference'''=
 
='''HemOnc.org - A Free Hematology/Oncology Reference'''=
  
−
'''<big><big>This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users.  For posterity, this page will remain here for now.  <br>[http://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_mobile If you wish to use the mobile version of the site, click here].
+
'''<big><big>This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users.  For posterity, this page will remain here for now.  <br>[https://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_mobile If you wish to use the mobile version of the site, click here].
 
</big></big>'''
 
</big></big>'''
 
<center>
 
<center>
 
{| class="wikitable"
 
{| class="wikitable"
 
|-
 
|-
−
| <div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}} regimens on HemOnc.org</b></font></div> || <div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on HemOnc.org</b></font></div>
+
| <div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}} [[Tutorial#Regimens|regimens]] on HemOnc.org</b></font></div> || <div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on HemOnc.org</b></font></div>
 
|}
 
|}
 
</center>
 
</center>
  
 
<center><big>'''[[Main Page | Desktop version of the main page]]<br>[[How to add HemOnc.org to your home screen | How to add a HemOnc.org shortcut to your mobile device's home screen]]'''</big></center>
 
<center><big>'''[[Main Page | Desktop version of the main page]]<br>[[How to add HemOnc.org to your home screen | How to add a HemOnc.org shortcut to your mobile device's home screen]]'''</big></center>
−
{| border="1" style="text-align:center;" style="color:white; font-size:225%; line-height:1.05em;"
+
{| class="wikitable" style="text-align:center;" style="color:white; font-size:225%; line-height:1.05em;"
 
!colspan="2" align="center" style="background-color:#696969"| Quick links to chemotherapy regimens
 
!colspan="2" align="center" style="background-color:#696969"| Quick links to chemotherapy regimens
 
|-
 
|-
Line 41: Line 41:
 
|-
 
|-
 
|style="height:50px" |[[Melanoma]]  
 
|style="height:50px" |[[Melanoma]]  
−
|[[Mesothelioma]]
+
|[[Malignant pleural mesothelioma]]
 
|-
 
|-
−
|style="height:50px" |[[Neuroendocrine tumors]]
+
|style="height:50px" |[[Neuroendocrine tumor]]
 
|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 
|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 
|-
 
|-
Line 53: Line 53:
 
|-
 
|-
 
|style="height:50px" |[[Rectal cancer]]
 
|style="height:50px" |[[Rectal cancer]]
−
|[[Renal cancer]]
+
|[[Renal cell carcinoma]]
 
|-
 
|-
 
|style="height:50px" |[[Soft tissue sarcoma]]  
 
|style="height:50px" |[[Soft tissue sarcoma]]  
Line 62: Line 62:
 
|-
 
|-
 
|style="height:50px" |[[Unknown primary]]  
 
|style="height:50px" |[[Unknown primary]]  
−
|[[Uterine cancer]]
+
|[[Endometrial cancer]]
 
|-
 
|-
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias'''
Line 74: Line 74:
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes'''
 
|-
 
|-
−
|style="height:50px" |[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]]
+
|style="height:50px" |[[Chronic myeloid leukemia | Chronic myelogenous leukemia (CML)]]
 
|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]]
 
|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]]
 
|-
 
|-
Line 91: Line 91:
 
|[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]]
 
|[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]]
 
|-
 
|-
−
|style="height:50px" |[[Chronic lymphocytic leukemia (CLL/SLL) | Chronic lymphocytic leukemia (CLL/SLL)]]
+
|style="height:50px" |[[Chronic lymphocytic leukemia | Chronic lymphocytic leukemia (CLL/SLL)]]
 
|[[CNS lymphoma]]
 
|[[CNS lymphoma]]
 
|-
 
|-
Line 97: Line 97:
 
|[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]]
 
|[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]]
 
|-
 
|-
−
|style="height:50px" |[[Extranodal NK/T-cell lymphoma, nasal type]]
+
|style="height:50px" |[[Extranodal NK- and T-cell lymphoma, nasal type]]
 
|[[Follicular lymphoma|Follicular lymphoma (FL)]]
 
|[[Follicular lymphoma|Follicular lymphoma (FL)]]
 
|-
 
|-
Line 103: Line 103:
 
|[[HIV-associated lymphoma]]
 
|[[HIV-associated lymphoma]]
 
|-
 
|-
−
|style="height:50px" |[[Hodgkin lymphoma|Hodgkin lymphoma (HL)]]  
+
|style="height:50px" |[[Classical Hodgkin lymphoma|Hodgkin lymphoma (HL)]]  
 
|[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]]
 
|[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]]
 
|-
 
|-
Line 115: Line 115:
 
|[[Multiple myeloma|Multiple myeloma (MM)]]
 
|[[Multiple myeloma|Multiple myeloma (MM)]]
 
|-
 
|-
−
|style="height:50px" |[[NK/T-cell lymphoma]]
+
|style="height:50px" |[[NK- and T-cell lymphoma]]
 
|[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]]
 
|[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]]
 
|-
 
|-
Line 127: Line 127:
 
|-
 
|-
 
|style="height:50px" |[[Aplastic anemia]]
 
|style="height:50px" |[[Aplastic anemia]]
−
|[[Autoimmune thrombocytopenic purpura (ITP)]]
+
|[[Immune thrombocytopenia (ITP)]]
 
|-
 
|-
−
|style="height:50px" |[[Castleman’s disease]]
+
|style="height:50px" |[[Castleman disease]]
 
|[[Coagulopathies]]
 
|[[Coagulopathies]]
 
|-
 
|-
Line 135: Line 135:
 
|[[Histiocytoses]]
 
|[[Histiocytoses]]
 
|-
 
|-
−
|style="height:50px" |[[Paroxysmal nocturnal hemoglobinuria (PNH)]]
+
|style="height:50px" |[[Paroxysmal_nocturnal_hemoglobinuria]]
−
|[[Venous thromboembolism (VTE)]]
+
|[[Venous_thromboembolism]]
 
|-
 
|-
 
|}
 
|}

Latest revision as of 19:32, 23 June 2024

HemOnc.org - A Free Hematology/Oncology Reference

This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users. For posterity, this page will remain here for now.
If you wish to use the mobile version of the site, click here.

4,428 regimens on HemOnc.org
6,544 variants on HemOnc.org
Desktop version of the main page
How to add a HemOnc.org shortcut to your mobile device's home screen
Quick links to chemotherapy regimens
Solid tumors
Anal cancer Bladder cancer
Bone sarcoma Breast cancer
Central nervous system (CNS) cancer Cervical cancer
Colon cancer Esophageal cancer
Gastric cancer Germ cell tumors
Head and neck cancer Hepatobiliary cancer
Lung cancer, non-small cell Lung cancer, small cell
Melanoma Malignant pleural mesothelioma
Neuroendocrine tumor Skin, basal & squamous cancer
Ovarian cancer Pancreatic cancer
Penile cancer Prostate cancer
Rectal cancer Renal cell carcinoma
Soft tissue sarcoma Testicular cancer
Thymoma Thyroid cancer
Unknown primary Endometrial cancer
Acute leukemias
Acute lymphocytic leukemia (ALL) Acute myeloid leukemia (AML)
Acute promyelocytic leukemia (APL) Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML)
Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Mast cell diseases Myelodysplastic syndrome
Primary & secondary myelofibrosis Polycythemia vera (PV)
Mature B-, T-, and NK-cell neoplasms
Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma
Chronic lymphocytic leukemia (CLL/SLL) CNS lymphoma
Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL)
Extranodal NK- and T-cell lymphoma, nasal type Follicular lymphoma (FL)
Hairy cell leukemia (HCL) HIV-associated lymphoma
Hodgkin lymphoma (HL) Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis
Mantle cell lymphoma (MCL) Marginal zone lymphoma (MZL)
Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM)
NK- and T-cell lymphoma Peripheral T-cell Lymphoma (PTCL)
Primary mediastinal B-cell lymphoma (PMBL) Transformed lymphoma (TL)
Transplant conditioning regimens Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia Immune thrombocytopenia (ITP)
Castleman disease Coagulopathies
Hemophagocytic lymphohistiocytosis (HLH) Histiocytoses
Paroxysmal_nocturnal_hemoglobinuria Venous_thromboembolism


Browse our complete index of pages


Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. Please see the desktop version of the main page for more information about HemOnc.org.

Retrieved from "https://hemonc.org/w/index.php?title=Main_Page_Mobile&oldid=86603"